Our guest for today's episode is Jimmy Lin, president and founder of the Rare Genomics Institute. He's also a senior TED fellow, which is how I got to know him. He's a big-hearted genius who is up to all kinds of exciting, world-changing things. The fact that he sat down long enough to talk with us is a real honor and I think you'll see why I'm such a fan of his. I hope you enjoy this conversation!
C. Jimmy Lin, MD, Ph.D., MHS is the Chief Scientific Officer (CSO) at Freenome, working on the early diagnosis of cancers. Previously, he was the CSO, Oncology at Natera (NASDAQ: NTRA), where he has led the development of new diagnostic technologies for cancer.
Jimmy is also a 2016 Senior TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease.
Previously, Jimmy led the ClinOmics program in the Genetics Branch of the National Cancer Institute (NIH/NCI). Prior to this, he led the computational analysis of the first-ever exome sequencing studies of cancer at Johns Hopkins and was a research instructor at Washington University in St. Louis. He has numerous publications in Science, Nature, Cell, Nature Genetics, and Nature Biotechnology, and has been featured in Forbes, Bloomberg, Wall Street Journal, New York Times, Washington Post, BBC, TIME, and the Huffington Post.
Learn more about Jimmy at DrJimmyLin.com and RareGenomics.org.